APTOCROM Inc. (KOSDAQ:109960)
 302.00
 -7.00 (-2.27%)
  At close: Oct 24, 2025
APTOCROM Company Description
APTOCROM Inc. distributes pharmaceutical products in South Korea.
It offers prescription and over-the-counter medication, such as antibiotics, antifungal agent, antiviral drugs, infusion solution, peptic ulcer medication, osteoarthritis treatment, purifying solvent, brain function improvement agent, respiratory solvent, topical medicine, adrenocorticosteroids, urinary medicine, hair loss treatment, antipyretic analgesic and anti-inflammatory agent, antihistamines, obesity agents, neural contract, liver extract, fire extinguisher solvent, etc. The company was formerly known as AP Healthcare Inc. and changed its name to APTOCROM Inc. in September 2025.
APTOCROM Inc. was founded in 1998 and is headquartered in Seongnam-si, South Korea.
APTOCROM Inc.
  | Country | South Korea | 
| Founded | 1998 | 
| Industry | Drugs, Drug Proprietaries, and Druggists' Sundries | 
| Employees | 14 | 
| CEO | Hui Chang | 
Contact Details
| Address: Halla Sigma Valley B1 Seongnam-si South Korea | |
| Phone | 82 31 8022 0595 | 
| Website | aprogen-hng.com | 
Stock Details
| Ticker Symbol | 109960 | 
| Exchange | KOSDAQ | 
| Stock Type | Common Stock | 
| Fiscal Year | January - December | 
| Reporting Currency | KRW | 
| SIC Code | 5122 | 
Key Executives
| Name | Position | 
|---|---|
| Hui Chang | Chief Executive Officer |